Abstract:BACKGROUND Gestational diabetes mellitus (GDM) is characterized by glucose intolerance that is first diagnosed during pregnancy, making it the most common complication associated with this period. Early detection and targeted treatment of GDM can minimize foetal exposure to maternal hyperglycaemia and subsequently reduce the associated adverse pregnancy outcomes. Previous studies have inconsistently suggested that the level of glycated albumin (GA) might predict GDM. AIM To review and synthesize existing evidence to evaluate the relationship between GA levels and the development of GDM. METHODS We sought to compare GA levels between GDM and control groups in this meta-analysis by systematically searching the Web of Science, PubMed, Cochrane Library, and Embase databases for articles published up to June 2023. The analysis utilized the weighted mean difference (WMD) as the primary metric. The data were meticulously extracted, and the quality of the included studies was assessed. Additionally, we conducted a subgroup analysis based on study region and sample size. We assessed heterogeneity using I 2 statistics and evaluated publication bias through funnel plots. Additionally, trim-and-fill analysis was employed to detect and address any potential publication bias. RESULTS The meta-analysis included a total of 11 studies involving 5477 participants, comprising 1900 patients with GDM and 3577 control individuals. The synthesized results revealed a notable correlation between elevated GA levels and increased susceptibility to GDM. The calculated WMD was 0.42, with a 95% confidence interval (95%CI) ranging from 0.11 to 0.74, yielding a P value less than 0.001. Concerning specific GA levels, the mean GA level in the GDM group was 12.6, while for the control group, it was lower, at 11.6. This discrepancy underscores the potential of GA as a biomarker for assessing GDM risk. Moreover, we explored the levels of glycated haemoglobin (HbA1c) in both cohorts. The WMD for HbA1c was 0.19, with a 95%CI ranging from 0.15 to 0.22 and a P value less than 0.001. This observation suggested that both GA and HbA1c levels were elevated in individuals in the GDM group compared to those in the control group. CONCLUSION Our meta-analysis revealed a substantial correlation between elevated GA levels and increased GDM risk. Furthermore, our findings revealed elevated levels of HbA1c in GDM patients, emphasizing the significance of monitoring both GA and HbA1c levels for early GDM detection and effective management.

Selection and Evaluation of Clinical Diagnostic Cut Point of Glycated Albumin

Assessment of enzymatic method for glycated albumin and its correlation research with the diagnosis of diabetes mellitus

[A Multi-Center Clinical Study of the Reference Value of Serum Glycated Albumin].

Clinical Utility of Glycated Albumin in Type 2 Diabetic Patients

Relationship between glycated albumin and glycated hemoglobin according to glucose tolerance status: A multicenter study

The diagnostic accuracy of HbA1c in detecting gestational diabetes mellitus among Chinese pregnant individuals

Relationship Between Hba1c and Continuous Glucose Monitoring in Chinese Population: A Multicenter Study

Cutoff Values for Glycated Albumin, 1,5‐Anhydroglucitol, and Fructosamine as Alternative Markers for Hyperglycemia

HbA 1c combined with glycated albumin or 1,5‐anhydroglucitol improves the efficiency of diabetes screening in a Chinese population

Correlation between glycosylated serum albumin and glycosylated haemoglobin in the southwest Chinese population: Establishment of a regression model

Cut-off value for glucose challenge test in Chinese women during pregnancy

HbA1c as screen tool for detection of diabetes mellitus in Chinese adults: A meta-analysis

Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: A multicenter, prospective study

Circulating glycated albumin levels and gestational diabetes mellitus

Association Between Glycated Albumin and Adverse Outcomes in Patients with Heart Failure.

Effect of age on the performance of hemoglobin A 1c and glycated albumin for screening diabetes

Predictive value of the glycated albumin versus glycosylated hemoglobin in follow-up of glucose homeostasis in hemodialysis-maintained type-2 diabetic patients

Multi Center Clinical Trial of Serum Glycated Albumin Enzyme Test

Assessment of Glycated Albumin As a Useful Indicator for Renal Dysfunction in Diabetic and Nondiabetic Population.

Performance of HbA1c for detecting newly diagnosed diabetes and pre-diabetes in Chinese communities living in Beijing

The Association of Retinopathy and Plasma Glucose and Hba1c: A Validation of Diabetes Diagnostic Criteria in A Chinese Population